Sirna acquired by Merck for US$1.1 B
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 78 (Table of Contents)
Published: 6 Dec-2006
DOI: 10.3833/pdr.v2006.i78.425 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Merck entered into an acquisition agreement to acquire Sirna Therapeutics, thus expanding its product portfolio with RNAi-based therapeutics...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018